TORNTPHARM — Torrent Pharmaceuticals Balance Sheet
0.000.00%
- IN₹1.58tn
- IN₹1.69tn
- IN₹139.80bn
Annual balance sheet for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,830 | 7,228 | 10,040 | 6,880 | 23,552 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19,216 | 22,371 | 21,948 | 22,598 | 36,962 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 52,947 | 53,292 | 56,115 | 56,226 | 93,919 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 32,469 | 34,598 | 35,778 | 38,229 | 53,660 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 130,998 | 150,119 | 150,606 | 149,897 | 443,120 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 44,151 | 54,473 | 54,253 | 47,172 | 83,433 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 71,469 | 88,138 | 82,044 | 73,991 | 359,235 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 59,530 | 61,981 | 68,562 | 75,907 | 83,884 |
| Total Liabilities & Shareholders' Equity | 130,998 | 150,119 | 150,606 | 149,897 | 443,120 |
| Total Common Shares Outstanding |